Cidara Therapeutics, Inc. (CDTX)
221.38
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Cidara Therapeutics Research and Development Expense (Quarterly) : 35.53M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.992B |
| Cogent Biosciences, Inc. | 74.38M |
| Olema Pharmaceuticals, Inc. | 39.95M |
| Rhythm Pharmaceuticals, Inc. | 45.92M |
| BridgeBio Pharma, Inc. | 112.87M |